First Time Loading...

Horizon Therapeutics PLC
NASDAQ:HZNP

Watchlist Manager
Horizon Therapeutics PLC Logo
Horizon Therapeutics PLC
NASDAQ:HZNP
Watchlist
Price: 116.3 USD Market Closed
Updated: May 6, 2024

Horizon Therapeutics PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Horizon Therapeutics PLC
Cash from Financing Activities Peer Comparison

Comparables:
ALKS
AMRN
PRTA
M
MURA

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Horizon Therapeutics PLC
NASDAQ:HZNP
Cash from Financing Activities
-$334.4m
CAGR 3-Years
-68%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Alkermes Plc
NASDAQ:ALKS
Cash from Financing Activities
-$289.7m
CAGR 3-Years
-409%
CAGR 5-Years
-183%
CAGR 10-Years
N/A
Amarin Corporation PLC
NASDAQ:AMRN
Cash from Financing Activities
$230k
CAGR 3-Years
N/A
CAGR 5-Years
-74%
CAGR 10-Years
-47%
Prothena Corporation PLC
NASDAQ:PRTA
Cash from Financing Activities
$45.1m
CAGR 3-Years
490%
CAGR 5-Years
2%
CAGR 10-Years
-6%
M
Mural Oncology PLC
NASDAQ:MURA
Cash from Financing Activities
$468.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Horizon Therapeutics PLC's Cash from Financing Activities?
Cash from Financing Activities
-334.4m USD

Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Cash from Financing Activities amounts to -334.4m USD.

What is Horizon Therapeutics PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-49%

Over the last year, the Cash from Financing Activities growth was -267%. The average annual Cash from Financing Activities growth rates for Horizon Therapeutics PLC have been -68% over the past three years , -49% over the past five years .